389470 — Inventage Lab Income Statement
0.000.00%
- KR₩391bn
- KR₩407bn
- KR₩2bn
Annual income statement for Inventage Lab, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 532 | 1,862 | 3,724 | 658 | 1,783 |
| Cost of Revenue | |||||
| Gross Profit | 532 | 1,627 | 3,322 | 584 | 1,754 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 6,069 | 11,420 | 14,625 | 16,551 | 20,747 |
| Operating Profit | -5,537 | -9,558 | -10,902 | -15,893 | -18,964 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -12,880 | -9,271 | -10,595 | -26,994 | -19,185 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -12,880 | -9,271 | -10,595 | -26,994 | -16,997 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -12,880 | -9,271 | -10,595 | -26,994 | -16,997 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -12,880 | -9,271 | -10,595 | -26,994 | -16,997 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1,566 | -1,165 | -1,457 | -3,146 | -1,854 |
| Dividends per Share |